Skip links and keyboard navigation

Public health and wellbeing > Health Support Queensland

Queensland Blood Management Program: About Us


The Commonwealth and all State and Territory Governments are signatories to the National Blood Agreement (Agreement) which came into effect on 1 July 2003.  The Agreement sets out the terms under which the Commonwealth, States and Territories enter into the implementation of a coordinated, national approach to policy setting, governance and management of the Australian blood sector.  Under this Agreement state and territory governments are required to:

  1. Foster the development and implementation of best practice planning and management systems for blood products and promote efficiency in use and minimisation of wastage;
  2. Ensure the provision of information and advice to the NBA, in relation to demand for blood products
  3. Obtain information and advice from the NBA in relation to available levels and prices for the supply of particular product.
  4. Undertake best practice management of the supply and use of blood products
  5. Comply with the agreed financial arrangements regarding the joint funding of the National blood supply.

The Queensland Minister for Health signed the National Blood Agreement on behalf of the Queensland Government in January 2003.  The Queensland Blood Management Program was established in July 2005 to ensure that that the Queensland Government meets it obligations under the Agreement. The specific objectives of the QBMP are to:

  1. Manage the escalating costs of the Queensland blood supply.
  2. Establish and improve communication, lines of accountability and reporting relationships between all elements in the blood transfusion service.
  3. Improve the accuracy of the supply planning process so as to better predict demand, future cost and budgeting.
  4. Develop and implement a quality and safety program for transfusion services in Queensland to "improve patient outcomes", ensure appropriate usage of blood and blood products and to reduce adverse events and improve patient outcomes.
  5. Take responsibility for clinical leadership and appropriate access to blood products under the National Blood Agreement.
  6. Ensure Queensland’s effective participation in policy formation and decision making under the terms of National Blood Agreement.
  7. Ensure effective and accountable management of the Queensland blood budget.

Last Updated: 27 March 2009
Last Reviewed: 27 March 2009